| Date | Title | Description |
| 29.04.2026 | New study demonstrates up to 73% reduction in genome analysis errors using AI-trained models versus standard approaches | SAN JOSE, Calif., April 29, 2026 /PRNewswire/ -- Complete Genomics, a U.S.-based leader in genomic sequencing technologies, today announced results demonstrating that AI-trained variant calling models can reduce genome analysis errors by up... |
| 02.03.2026 | Swiss Rockets Acquires Complete Genomics | Swiss Rockets AG, a Basel, Switzerland-based provider of life sciences incubation and biotechnology acceleration, acquired Complete Genomics, a San Jose, California-based provider of genomic sequencing technology.
The amount of the deal was... |
| 02.03.2026 | Augmented Intelligence Acquires Quack AI | Augmented Intelligence (AUI) Inc., a New York City-based provider of neuro-symbolic artificial intelligence models, acquired Quack AI, a Tel Aviv, Israel-based provider of trainable AI customer service agents.
The amount of the deal was not... |
| 25.02.2026 | Swiss Rockets acquires Complete Genomics |
Founded in 2018, the Swiss Rockets Group is an innovative umbrella company with a portfolio of several niche-leading biotech companies ranging from late-stage pre-clinical to Phase III. Its portfolio with a focus on oncology includes proje... |
| 24.02.2026 | Chinese Gene Sequencing Firm MGI to Sell US Unit to Swiss Rockets Amid Geopolitical Risks | (Yicai) Feb. 24 -- MGI Tech, a Chinese supplier of gene-sequencing equipment, has agreed to sell its US subsidiary to Swiss life sciences group Swiss Rockets to avoid geopolitical risks.
MGI will sell 100 percent of Complete Genomics, a US-... |
| 14.10.2025 | Complete Genomics Highlights New Products, Partnerships, First DNBSEQ User Group Meeting at ASHG 2025 | BOSTON, Oct. 14, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a series of milestones at the American Society of Human Genetics (ASHG) Annual Meeting, Oct. 14–18, 2025 in Boston.
At ASHG ... |
| 13.10.2025 | Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG | BOSTON, Oct. 13, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced at the American Society of Human Genetics Annual Meeting that it has added Houston-based Gene by Gene, a leading genetics la... |
| 28.04.2025 | Complete Genomics, Velsera partner to integrate sequencing and analysis platforms | CHICAGO, April 28, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing announced a collaboration with Velsera, a leading global healthcare technology company, to deliver an end-to-end genetic testing solution t... |
| 17.04.2025 | Spatial Omics: A New Frontier in Genomic Research | In the realm of genomic research, a new star is rising. Spatial omics is the name of the game. It’s a powerful tool that promises to unlock the mysteries of complex diseases. Recently, Complete Genomics announced the winners of its Spatial ... |
| 15.04.2025 | Complete Genomics Names Four Winners of Spatial Xcellerator Grant Program | SAN JOSE, Calif., April 15, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced four winners from 30 applicants to its Spatial Xcellerator Grant Program. Winning projects address oncology, pedi... |
| 26.03.2025 | Complete Genomics and BioTuring: A New Era in Spatial Biology | In the bustling world of genomics, innovation is the lifeblood. Complete Genomics, a trailblazer in DNA sequencing, is making waves once again. At the NextGen Omics & Spatial Biology Conference, they unveiled a partnership with BioTurin... |
| 25.03.2025 | Complete Genomics Announces Partnership with BioTuring and the Go Optical STOmics microscope. | SAN JOSE, Calif., March 25, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has partnered with BioTuring, developer of advanced bioin... |
| 25.03.2025 | Complete Genomics Announces Commercial Partnership with Human Cell Atlas to Offer its Members Stereo-seq Spatial Transcriptomics at NextGen Omics & Spatial Biology Conference | SAN JOSE, Calif., March 25, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has entered a commercial partnership with Human Cell Atla... |
| 24.02.2025 | Complete Genomics unveils DNBSEQ-T1+ and DNBSEQ-E25 Flash at AGBT 2025 General Meeting | MARCO ISLAND, Fla., Feb. 24, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today unveiled its latest high-performance sequencing solutions at the 2025 Advances in Genome Biology and Technology (AGBT) Gen... |
| 10.01.2025 | In 2024, Complete Genomics expanded U.S. manufacturing and technology capabilities toward a diversified, reliable supply chain for its flexible and cost-effective NGS solutions | SAN JOSE, Calif., Jan. 10, 2025 /PRNewswire/ -- In 2024, Complete Genomics, a pioneering genomic sequencing company, expanded its U.S. manufacturing footprint with augmented technology capabilities to diversify its supply chain helping it t... |
| 17.12.2024 | Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program | FRAMINGHAM, Mass., Dec. 17, 2024 /PRNewswire/ -- Complete Genomics, a San Jose, California based genomics tools manufacturer, today announced Framingham, Massachusetts based Eurofins Clinical Enterprise, LLC as the newest addition to its Se... |
| 21.11.2024 | Complete Genomics announces mpox virus amplicon sequencing panel at AMP | VANCOUVER, BC, Nov. 21, 2024 /PRNewswire/ -- Complete Genomics, a San Jose, Calif.-based genomic sequencer manufacturer, today announced at the 2024 Association for Molecular Pathology (AMP) Annual Meeting & Expo the launch of its mpox ... |
| 05.11.2024 | Complete Genomics Announces Spatial Omics Distributor Agreement, Debuts Spatial Xcellerator Grant Program at SITC 2024 | HOUSTON, Nov. 5, 2024 /PRNewswire/ -- At the Society for Immunotherapy of Cancer (SITC) Annual Meeting (Nov. 6-10, 2024), Complete Genomics, a pioneering genomic sequencing company, is pleased to announce the launch of its Spatial Xcellerat... |
| 29.10.2024 | Complete Genomics integrates NVIDIA Parabricks to offer researchers faster, more cost-effective and accurate genomic sequencing analysis | Complete Genomics DNBSEQ data and NVIDIA Parabricks yield deeper insights into genetic variants with deep learning
SAN JOSE, Calif., Oct. 29, 2024 /PRNewswire/ -- Complete Genomics today announced an integration of its next-generation seque... |
| 23.09.2024 | AdvancedDx Biological Laboratories USA Inc. and Complete Genomics LLC to co-market NGS microbiology solution in the U.S. | NEWBURYPORT, MA, UNITED STATES, September 23, 2024 /EINPresswire.com/ -- AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular bi... |
| 11.09.2024 | The Rising Tide of Genomic Innovation: MGI's CycloneSEQ Technology and the Political Storm Surrounding Biotech | In the world of biotechnology, innovation is the lifeblood that fuels progress. MGI Tech Co., Ltd. has recently unveiled its latest advancements in nanopore sequencing technology, the CycloneSEQ-WT02 and CycloneSEQ-WY01. These products prom... |
| 07.09.2024 | Democrat to vote against bill restricting China's WuXi Biologics, BGI | Boards, Policy & RegulationHuman Rights
Democrat to vote against bill restricting China's WuXi Biologics, BGI
By Karen FreifeldSeptember 7, 20243:30 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Emai... |
| 23.05.2024 | Complete Genomics opens U.S. supply chain to genomic sequencing customers through a new manufacturing facility at its San Jose, Calif. headquarters | SAN JOSE, Calif., May 23, 2024 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, recently welcomed vendors, suppliers, customers and employees to a May 17 grand opening celebration of its 10,115 square foot manufac... |
| 21.05.2024 | Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston's Biotech Hub | The laboratory gives researchers a training ground for state-of-the-art DNBSEQ technology to further precision diagnostics and treatments
SAN JOSE, Calif., May 21, 2024 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing comp... |
| 10.04.2024 | Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility | Apr 10 2024
ORMOND BEACH, FL and GERMANTOWN, MD —— Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (Nasdaq: ORGS), a global leader in decentralizing cell and gene therapies (CGTs), today an... |
| 06.03.2024 | US Senate Debates Bill Targeting Chinese Biotech Giants WuXi Apptec, BGI Over National Security Concerns | Quincy Jon, Tech Times 06 March 2024, 08:03 am
In a significant development on Capitol Hill, a groundbreaking bill in the U.S. Senate is poised for its inaugural examination in Congress on Wednesday.
This legislation, strategically crafted ... |
| 27.02.2024 | Germfree Announces the Appointment of Four Independent Board Members | Feb 27 2024
Ormond Beach, Florida – Germfree announces the appointments of Dorothy Puhy, Karen Flynn, Kerry Ingalls and Helga Salling as independent non-executive members of its Board of Directors.
“We are excited to welcome Dorothy, Kare... |
| 07.02.2024 | Complete Genomics and seqWell Announce Codevelopment Partnership at AGBT | Companies will work together to offer fast, cost-effective ultra-high-throughput library preparation workflows
SAN JOSE, Calif. and BEVERLY, Mass., Feb. 7, 2024 /PRNewswire/ -- Complete Genomics, a life sciences company specializing in end-... |
| 06.02.2024 | At AGBT, Complete Genomics showcases expanded sequencing applications, talks from customers and collaborators on research powered by the DNBSEQ-T7 Sequencer | The genomic sequencing solutions provider also introduces Q40 sequencing quality, announces new DNBSEQ products
SAN JOSE, Calif., Feb. 6, 2024 /PRNewswire/ -- Complete Genomics, a California-based life sciences company that provides novel, ... |
| 16.01.2024 | Complete Genomics and Gencove Announce agreement at Plant and Animal Genome Conference (PAG 31) to offer a bundled solution for low-pass whole genome sequencing | SAN JOSE, Calif., Jan. 16, 2024 /PRNewswire/ -- Complete Genomics, a life sciences company that provides novel, end-to-end DNA sequencing solutions, today announced a joint marketing agreement with Gencove, a pioneer of low-pass whole genom... |
| 16.11.2023 | Complete Genomics opens $3.2 million manufacturing facility at its San Jose headquarters | SAN JOSE, Calif., Nov. 16, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced plans for the opening of a $3.2 million manufacturing facility within its headquarters in San Jose, California. The ... |
| 08.11.2023 | Complete Genomics' DNBSEQ-T20x2RS* Named "Next Generation Sequencing Solution of the Year" by 2023 BioTech Breakthrough Awards Program | Third Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industry
SAN JOSE, Calif., Nov. 8, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced it is the re... |
| 02.11.2023 | Complete Genomics and Basepair™ Announce Technology Integration Partnership | SAN JOSE, Calif. and NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Complete Genomics and Basepair, Inc today announced a technology integration partnership to accelerate the analysis and interpretation of genomic data generated by Complete Genomic... |
| 31.10.2023 | Complete Genomics demonstrates technical and commercial momentum in the sequencing market through new customers, partnerships and collaborations less than one year after launching in the U.S. | WASHINGTON, Oct. 31, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, announced today at the American Society of Human Genetics (ASHG) Annual Meeting, Nov. 1-5, in Washington details on the commercial and tec... |
| 18.10.2023 | Complete Genomics Partners with Integrated DNA Technologies to Establish New Ecosystem of NGS Products | SAN JOSE, California, Oct. 18, 2023 /PRNewswire/ -- Complete Genomics, Inc., a pioneering genomic sequencing company, today announced its partnership with Integrated DNA Technologies (IDT), a global genomics solutions provider, to develop a... |
| 23.08.2023 | Complete Genomics Garners the Prestigious 2023 R&D 100 Awards for Cutting-Edge Innovation | SAN JOSE, Calif., Aug. 23, 2023 /PRNewswire/ -- Complete Genomics, Inc., a pioneering genomic sequencing company, today proudly received the honor of the R&D 100 Awards from R&D World Magazine, often referred to as the "Oscars ... |
| 18.07.2023 | VitalConnect Secures over $30 Million in Oversubscribed Series F Financing | Jul 18 2023
New funding to accelerate company’s strong commercial momentum
SAN JOSE, California—(BUSINESS WIRE)—VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced closing on an oversubsc... |
| 18.05.2023 | EW Healthcare Partners Announces Platform Investment in Enercon Technologies | May 18 2023
Leading electronics-focused design, engineering, and product manufacturing capabilities position Enercon for continued growth in medical devices and life sciences
Leading electronics-focused design, engineering, and product ma... |
| 07.02.2023 | Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting | DNBSEQ-T20×2*produces up to 50,000 WGS per year at a first sub hundred-dollar price per genome
DNBSEQ-T7* offers an outstanding $1.5/Gb price for sequencing consumables
DNBSEQ-G99* delivers a first-in-class PE150 run within 12 hours with a ... |
| 24.01.2023 | Complete Genomics to Announce New Product Launches at AGBT General Meeting | SAN JOSE, Calif., Jan. 24, 2023 /PRNewswire/ -- Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. ("MGI"), today announced it plans to launch three new products at the Advances in Geno... |
| 10.01.2023 | Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase™ 2023 | SAN FRANCISCO, Jan. 10, 2023 /PRNewswire/ -- Complete Genomics Inc (https://completegenomics.mgiamericas.com/), a subsidiary of MGI Tech Co., Ltd. ("MGI"), today unveiled its full sequencing platforms at Biotech Showcase during JP... |
| 30.12.2022 | Complete Genomics to Present its Multiple, Innovative Sequencing Platforms at BIOTECH SHOWCASE™ 2023 | Enhanced sequencing capabilities offer opportunity to accelerate breakthroughs in life science research
SAN JOSE, Calif., Dec. 30, 2022 /PRNewswire/ -- Complete Genomics Inc（https://completegenomics.mgiamericas.com/）, a subsidiary of MGI Te... |
| 14.12.2022 | Frost & Sullivan Recognizes VitalConnect with the 2022 New Product Innovation Award for Its Leading-edge Wearable Patient Monitoring Device | Dec 14 2022
VitalConnect delivers a cost-effective, 24/7 remote patient monitoring platform that outperforms existing patient monitoring devices on the market.
SAN ANTONIO, Texas —— Based on its recent analysis of the wearable biosensor i... |
| 01.11.2022 | BioTissue Completes Name Change | Nov 01 2022
MIAMI,Florida — BioTissue Holdings Inc., announced today the completion of its name change from TissueTech, Inc. The change is part of a corporate-wide branding initiative launched earlier this year to better represent the comp... |
| 18.10.2022 | EW Healthcare Partners Acquires Germfree Laboratories, Inc. | Oct 18 2022
Manufacturer positioned to deliver solutions to ease space constraints in the fast-growing cell and gene therapy sector.
New York, NY, and Ormond Beach, FL – EW Healthcare Partners announced today that it has acquired Germfree... |
| 16.08.2022 | VitalConnect Appoints Amy Covert as Chief Financial Officer | Aug 16 2022
Addition of Experienced Financial Leader Bolsters Strong Management Team
SAN JOSE, California—(BUSINESS WIRE)—VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the appointme... |
| 09.08.2022 | VitalConnect Announces Addition of Heather Getz to Board of Directors | Aug 09 2022
Getz adds 25 Years of Financial and Healthcare Leadership to Growing Company
SAN JOSE, California—(BUSINESS WIRE)—VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the addit... |
| 05.05.2022 | EW Healthcare Partners Announces the Acquisition of a Majority Stake in Grundium Oy | May 05 2022
LONDON (Newswire.com) - EW Healthcare Partners (“EW”) has acquired a majority stake in Grundium Oy (“Grundium”), a leader in advanced imaging technology based in Finland. The founders and management of Grundium will retain a si... |
| 27.01.2022 | Ted Davis to Succeed Amy Tseng as President and CEO of TissueTech | Jan 27 2022
MIAMI—(BUSINESS WIRE)—TissueTech, Inc., a pioneer in the clinical application of cryopreserved human birth tissue products to treat ocular surface disease and disorders, chronic wounds, and musculoskeletal conditions, has named... |
| 10.01.2022 | VitalConnect Announces Closure of $39 Million Round of Growth Financing | Jan 10 2022
Series E Financing led by EW Healthcare Partners with Robert S White to Join Board
SAN JOSE, California —— VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the completion o... |
| 20.10.2021 | Laboratoires Majorelle appoints Alexandre de Germay as Chief Executive Officer | Oct 20 2021
PARIS, France—Laboratoires Majorelle, a fast-growing French specialty pharma company focused on prescription and OTC products in women’s health and urology, today announces the appointment of Alexandre de Germay as Chief Execut... |
| 04.10.2021 | EW Healthcare Partners Announces the Promotion of Senior Executives | Oct 04 2021
NEW YORK, New York – EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the promotion of senior executives of their investment team.
• Brooks Andrews has bee... |
| 30.04.2021 | EW Healthcare Partners Announces the Acquisition of a Majority Stake in Laboratoires Majorelle | Apr 30 2021
London, UNITED KINGDOM—EW Healthcare Partners (“EW”) has acquired a majority stake in Laboratoires Majorelle (“Majorelle”) from its Founders to support its growth and European expansion in line with the Founders’ strategy.
Hea... |
| 30.03.2021 | Bioventus Acquires Bioness, Inc. | Mar 30 2021
DURHAM, North Carolina –– Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc. (“Bioness”), a global leader in neuromodulation and rehabilita... |
| 29.03.2021 | Charles River Laboratories Completes the Acquisition of Cognate BioServices | Mar 29 2021
WILMINGTON, Mass.—(BUSINESS WIRE)—Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Cognate BioServices, Inc. for approximately $875 million... |
| 17.02.2021 | Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development | Feb 17 2021
– Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector –
– Combines Cognate’s Comprehensive Cell and Gene Therapy CDMO Capabilities to Establish an Integrated Solution f... |
| 28.01.2021 | EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of EYP-1901 for the Treatment of Wet AMD | Jan 28 2021
WATERTOWN, Massachusetts (GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye d... |
| 20.01.2021 | Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio | Jan 20 2021
BOSTON, Massachusetts—PRNewswire—Haemonetics Corporation (NYSE: HAE) (“Haemonetics”), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that... |
| 14.07.2020 | Cardiva Medical Announces $45 Million Financing Led by EW Healthcare Partners | Jul 14 2020
Robert S. White Joins Board of Directors
SANTA CLARA, California (GLOBE NEWSWIRE)—Cardiva Medical, Inc, an innovator in the field of vascular closure, today announced the completion of a $45 million equity financing round. The... |
| 02.07.2020 | MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings | Jul 02 2020
Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Management. EW Healthcare Partners Managing Director and Co-Founder Martin Sutter and Former Medtronic Chairman and CEO William Hawkin... |
| 16.06.2020 | Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate | Jun 16 2020
Providing large scale manufacturing capacity for AZD1222
Keele, UK, 16 June 2020: Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, today announced it has... |
| 30.04.2020 | Xenex LightStrike Robot Destroys SARS-CoV-2 (Coronavirus) in 2 Minutes; First & Only UV Disinfection Technology Proven to Deactivate COVID-19 Virus | Apr 30 2020
San Antonio – April 30, 2020 — SARS-CoV-2 is a global threat for which the world was unprepared. Xenex Disinfection Services announced today that its LightStrike™ pulsed xenon disinfection robot is the first and only ultraviole... |
| 21.01.2020 | Cognate BioServices closes Series B and completes acquisition of Cobra Biologics | Jan 21 2020
MEMPHIS, Tennessee—Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products today announced that it has completed the acquisition of C... |
| 06.01.2020 | Sonendo® Announces Growth Investment from EW Healthcare Partners | Jan 06 2020
Leading Dental Technology Company Raises $85 Million to Accelerate Growth
LAGUNA HILLS, California—Sonendo, Inc., a leading dental technology company, announced today that EW Healthcare Partners, a global healthcare growth equ... |
| 29.11.2019 | Knight Therapeutics Announces Closing of Previously Announced Acquisition of Grupo Biotoscana | Nov 29 2019
MONTREAL, Canada—Knight Therapeutics Inc. (TSX: GUD) (“Knight”) today announced that it has completed the acquisition of a 51.2% interest in Biotoscana Investments S.A. (B3: GBIO33) (“GBT” or “Grupo Biotoscana”) from a controll... |
| 26.08.2019 | Cognate BioServices Secures Growth Capital Investment from EW Healthcare to Continue to Expand Commercial Manufacturing Capacity and Services for the Cellular Therapies Industry | Aug 26 2019
BALTIMORE & MEMPHIS, Tennessee –(BUSINESS WIRE)–Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, announced today it has secured a financi... |
| 22.08.2019 | EW Healthcare Partners Raises Over $745 Million Fund 2 | Aug 22 2019
Team of Experienced Healthcare Investors and Former Healthcare Executives Will Invest in Select Healthcare Companies to Seek to Accelerate Their Revenue Growth
Partner and Principals Promoted in London, New York and Palo Alto ... |
| 08.07.2019 | LightStrike Robot Proven Effective at Destroying Deadly Superbug Candida auris in New Published Study | Jul 08 2019
SAN ANTONIO—(BUSINESS WIRE)—Candida auris (C.auris) is an emerging, often multi-drug resistant, fungus that causes serious and often deadly infections in healthcare settings. The Centers for Disease Control & Prevention (CD... |
| 01.07.2019 | EyePoint Pharmaceuticals Added to Russell 3000® and 2000® Indexes | Jul 01 2019
WATERTOWN, Massachusetts—(GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) (“Eyepoint”), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today annou... |
| 26.06.2019 | TissueTech Raises $82 Million in Latest Round of Equity Financing | Jun 26 2019
EW Healthcare Partners Managing Director Martin Sutter and Former Medtronic CEO Bill Hawkins join TissueTech Board of Directors
(PRWEB) MIAMI, Florida—TissueTech, Inc., the pioneer in regenerative medicine utilizing human umbi... |
| 02.04.2019 | Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®. | Apr 02 2019
MALVERN, Pennsylvania—Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well as rights to market and distribute TRIANEX® 0.05% (Triamcinolone Acetonid... |
| 08.01.2019 | Vestar-backed Healthgrades Buys Influence Health | Jan 08 2019
Healthgrades, a Vestar Capital Partners portfolio company, said Jan. 8 that it acquired Influence Health. Financial terms weren’t announced. Influence Health, of Birmingham, Alabama, provides patient engagement software and hea... |
| 27.11.2018 | Gurnet Point Capital Completes Tender Offer for Corium International, Transaction Valued in Excess of $500 Million | Nov 27 2018
CAMBRIDGE, Mass.—(BUSINESS WIRE)—Gurnet Point Capital (“Gurnet Point”), a private investment firm focused on the healthcare and life sciences sectors, announced today that it has completed the previously announced tender offer ... |
| 19.11.2018 | Axogen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day | Nov 19 2018
Updates Value of the Market Opportunity in Existing Applications from $2.2 Billion to $2.7 Billion
Announces Market Development and Clinical Initiatives for Expanded Application in the Surgical Treatment of Chronic Neuropathic... |
| 11.10.2018 | Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares | Oct 11 2018
Total Transaction Valued in Excess of $500 Million, Representing a 50% Premium
Gurnet Point Capital to Expand Operations While Focusing on the Approval and Commercialization of Corium’s Corplex Donepezil
MENLO PARK, Californi... |
| 10.10.2018 | EW Healthcare Partners Announces the Appointment of Two Senior Executives | Oct 10 2018
NEW YORK, New York – EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the addition of two senior executives to their investment team:
• Olivier Bohuon, for... |
| 18.07.2018 | EUSA Pharma Announces Acquisition of Global Rights to SYLVANT (siltuximab) from Janssen Sciences Ireland UC for $115 Million | Jul 18 2018
HEMEL HEMPSTEAD, England – – EUSA Pharma (EUSA), a biopharmaceutical company focused on oncology and rare diseases, announced today that it has entered into a definitive agreement with Janssen Sciences Ireland UC, a subsidiary ... |
| 08.06.2018 | AxoGen Chairman and CEO Karen Zaderej Named Entrepreneur of the Year 2018 Award Winner in Florida | Jun 08 2018
ALACHUA, Florida—(GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Ernst & Young (EY) named AxoGen Chairman an... |
| 28.03.2018 | pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners - Company will Rebrand as EyePoint Pharmaceuticals, Inc... | Mar 28 2018
WATERTOWN, Massachusetts(GLOBE NEWSWIRE)—pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced the acquisition o... |
| 07.03.2018 | EUSA Pharma Appoints Industry Veteran Rolf K Hoffmann to its Board of Directors | Mar 07 2018
HEMEL HEMPSTEAD, England –– EUSA Pharma (EUSA), a world-class specialty pharmaceutical company focused on oncology and oncology supportive care, today announced the appointment of Rolf K Hoffmann to its Board of Directors. Mr H... |
| 21.02.2018 | Cota Announces $40 Million Series C Financing to Advance Classification System | Feb 21 2018
NEW YORK, NY—Cota Inc., a healthcare real-world evidence and data analytics company bridging precision medicine to population health, today announced the completion of a Series C round of financing led by IQVIA (NYSE:IQV) with ... |
| 15.11.2017 | EUSA Pharma and AVEO Oncology Announce First Commercial Launch of FOTIVDA (tivozanib) | Nov 15 2017
HEMEL HEMPSTEAD, England & CAMBRIDGE, Massachusetts. – – EUSA Pharma and AVEO Oncology (NASDAQ: AVEO) today announced the first commercial launch of FOTIVDA® (tivozanib) with the initiation of product sales in Germany. In t... |
| 18.10.2017 | EW Healthcare Partners Announces the Appointment of Three Senior Executives | Oct 18 2017
NEW YORK, New York—EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the addition of three senior executives to their investment team:
• Lamberto Andreotti,... |
| 03.10.2017 | Grupo Biotoscana and EISAI Sign Licensing Agreement for Four Oncology & Neurology Products in LatAm | Oct 03 2017
MONTEVIDEO, Uruguay and WOODCLIFF LAKE, New Jersey—GBT-Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical company in Latin America, today announced that it has entered into an exclusive licensing agreement with Eisai In... |
| 30.08.2017 | Grupo Biotoscana Expands Partnership with Gilead Sciences in HCV in Brazil | Aug 30 2017
Montevideo, Uruguay—GBT-Grupo Biotoscana (B3: GBIO33), a leading specialty pharmaceutical company in Latin America, today announced that it has expanded its partnership with Gilead Sciences (Nasdaq: GILD) in HCV in Brazil. Unde... |
| 02.08.2017 | AxoGen, Inc Reports 2017 Second Quarter Financial Results, Representing 46% Growth over Prior Year | Aug 02 2017
ALACHUA, Fla., (GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for t... |
| 27.07.2017 | Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year | Jul 27 2017
DANVERS, Massachusetts— Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2018 revenue of $132.5 million, an increase of 29% compared to revenue of ... |
| 21.07.2017 | Grupo Biotoscana Raises $417 Million in Oversubscribed Brazil IPO | Jul 21 2017
LONDON, United Kingdom—EW Healthcare Partners (“EWHP”), a global healthcare growth equity investor, announced that Grupo Biotoscana (“Biotoscana”), a Pan-Latin American specialty pharmaceutical company focused on oncology and c... |
| 13.07.2017 | Venus Concept Closes $38 Million Equity Financing to Support Continued Growth Opportunities | Jul 13 2017
TORONTO, Canada—Venus Concept Ltd., a privately-held and innovative global aesthetic technology leader, today announced the closing of a $38 million equity investment. The equity investment was led by EW Healthcare Partners alo... |
| 23.06.2017 | EUSA Pharma Receives Positive CHMP Opinion for Tivozanib for First-Line Treatment | Jun 23 2017
HEMEL HEMPSTEAD, England – – EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, today announced that the European Medicines Agency’s Committee for Medicinal Products fo... |
| 17.05.2017 | Endologix Provides an Update on the Nellix Endovascular Aneurysm Sealing System US Regulatory Status | May 17 2017
IRVINE, California – Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that the Company met with the Food and Drug Administration (FDA) regarding its Nellix®... |
| 09.05.2017 | European Commission Approves the Only Immunotherapy for High-Risk Neuroblastoma | May 09 2017
HEMEL HEMPSTEAD, England – EUSA Pharma today announced that the European Commission (EC) has approved the antibody ch14.18/CHO, dinutuximab beta, for the treatment of high-risk neuroblastoma in patients aged 12 months and above... |
| 27.03.2017 | EUSA Pharma and Apeiron Biologics Receive Positive CHMP Opinion for Dinutuximab Beta | Mar 27 2017
HEMEL HEMPSTEAD, England and VIENNA, Austria – – EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, and Apeiron Biologics today announced that the European Medicines Ag... |
| 14.02.2017 | Endologix Completes Patient Enrollment in the Ovation LUCY Study | Feb 14 2017
IRVINE, California (GLOBE NEWSWIRE)—Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the LUCY (Evaluation of FemaLe... |
| 15.12.2016 | A new kid on the consumer genomics block | As part of the consumer launch, the company also announced partnerships with The Utah Foundation for Biomedical Research, The Prion Alliance, and several companies within Patrick Soon-Shiong’s Nantworks empire, including Nantbioscience and ... |
| 06.12.2016 | Prolacta Bioscience Raises $35 Million in Mezzanine Financing | Dec 06 2016
CITY OF INDUSTRY, California – Prolacta Bioscience®, the nation’s leading provider of human milk-based neonatal nutritional products, today announced the closing of a $35 million mezzanine round of financing. The transaction wa... |
| 05.12.2016 | Metabolon Raises Additional $15 Million in Funding from Essex Woodlands | Dec 05 2016
RESEARCH TRIANGLE PARK, N.C. – – Metabolon, Inc., the global leader in metabolomics, announced today that it has raised an additional $15 million in funding from investor Essex Woodlands, a leading healthcare growth equity firm... |
| 11.08.2016 | Metabolon Closes $15 Million Financing to Support Precision Medicine Growth Opportunities | Aug 11 2016
RESEARCH TRIANGLE PARK, N.C. –– Metabolon, Inc., the global leader in metabolomics, announced today that it has closed a financing that raised $15 million from new investor Essex Woodlands, a leading healthcare growth equity fi... |
| 25.07.2016 | Pierre Fabre Pharmaceuticals and Grupo Biotoscana enter into a Commercialization Agreement | Jul 25 2016
Castres (France) and Montevideo (Uruguay) – July 25, 2016 – Pierre Fabre Pharmaceuticals, the second-largest French private pharmaceutical laboratory and Grupo Biotoscana SL (GBT), a leading specialty pharmaceutical company in ... |
| 11.04.2016 | Endologix Announces CE Mark for Next-Generation Nellix(R) EndoVascular Aneurysm Sealing System | Apr 11 2016
IRVINE, California (GLOBE NEWSWIRE)—Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today achievement of CE (Conformite Europeenne) Mark of the next-generation Nell... |
